World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
82
Citations
20674
World Ranking
1526
National Ranking
763

Julie Y. Djeu publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Julie Y. Djeu sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 274 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Julie Y. Djeu D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Julie Y. Djeu sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 82 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Julie Y. Djeu is affiliated with the University of South Florida in the United States. Their research primarily focuses on the fields of Immunology and Microbiology, with notable subfields including Immunology and Oncology.

Their scientific contributions address several key topics within immune system research, including:

  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses

Djeu's recent publications illustrate an engagement with natural killer (NK) cell biology and tumor immunology. One paper titled "Engineered Three-Dimensional Tumor Models to Study Natural Killer Cell Suppression," published in 2020 in ACS Biomaterials Science & Engineering, explores experimental models to understand NK cell behavior in tumor environments.

Another 2020 publication, "MicroRNA-155 governs SHIP-1 expression and localization in NK cells and regulates subsequent infiltration into murine AT3 mammary carcinoma," appeared in PLoS ONE, focusing on regulatory mechanisms affecting NK cell infiltration in cancer contexts.

Frequent collaborators in their research include Madison N. Temples, Isaac M. Adjei, Phoebe M. Nimocks, Blanka Sharma, and Wendy Kandell, indicating a network of ongoing coauthorship within their projects.

Their publications are featured in venues such as ACS Biomaterials Science & Engineering and PLoS ONE, highlighting interdisciplinary engagement between biomaterials science and broader biomedical research.

Best Publications

  • Natural Killer Cells: Characteristics and Regulation of Activity

    Ronald B. Herberman;Ronald B. Herberman;Ronald B. Herberman;Julie Y. Djeu;Julie Y. Djeu;Julie Y. Djeu;H. David Kay;H. David Kay;H. David Kay;John R. Ortaldo;John R. Ortaldo;John R. Ortaldo

  • Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

    Elizabeth Ann Grimm;Keith M. Ramsey;Amitabha Mazumder;Debra J. Wilson

  • A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers

    Krithika N. Kodumudi;Karrune Woan;Danielle L. Gilvary;Eva Sahakian

  • Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.

    A H Rook;H Masur;H C Lane;W Frederick

  • Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells.

    Kun Jiang;Bin Zhong;Danielle L. Gilvary;Brian C. Corliss

  • Circulating activated suppressor T lymphocytes in aplastic anemia.

    Nicholas C. Zoumbos;Pedro Gascón;Julie Y. Djeu;Stephen R. Trost

  • Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo.

    Nicholas C. Zoumbos;Pedro Gascon;Julie Y. Djeu;Neal S. Young

  • Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor.

    J Y Djeu;D K Blanchard;D Halkias;H Friedman

  • Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells.

    Ronald B. Herberman;Myrtel E. Nunn;Howard T. Holden;Steven Staal

  • Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein.

    James Turkson;Tammy Bowman;Jalila Adnane;Yi Zhang

  • Induction of myelodysplasia by myeloid-derived suppressor cells.

    Xianghong Chen;Erika A. Eksioglu;Junmin Zhou;Ling Zhang

  • Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor.

    T Kasahara;J Y Djeu;S F Dougherty;J J Oppenheim

  • Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8.

    J Y Djeu;K Matsushima;J J Oppenheim;K Shiotsuki

  • Human large granular lymphocytes are potent producers of interleukin-1

    Giuseppe Scala;Paola Allavena;Julie Y. Djeu;Tadashi Kasahara

  • Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors.

    Pearlie K. Epling-Burnette;Fanqi Bai;Jeffrey S. Painter;Dana E. Rollison

  • Cooperative regulation of Mcl-1 by Janus kinase/stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils

    P. K. Epling-Burnette;Bin Zhong;Fanqi Bai;Kun Jiang

  • Mechanistic role of heat shock protein 70 in Bcr-Abl–mediated resistance to apoptosis in human acute leukemia cells

    Fei Guo;Celia Sigua;Purva Bali;Prince George

  • Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses.

    J Y Djeu;N Stocks;K Zoon;G J Stanton

  • A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide

    Sheng Wei;Xianghong Chen;Kathy Rocha;P. K. Epling-Burnette

  • TGF-β–inducible microRNA-183 silences tumor-associated natural killer cells

    Sarah S. Donatelli;Jun-Min Zhou;Danielle L. Gilvary;Erika A. Eksioglu

  • Regulation of the mitogen-activated protein kinase signaling pathway by SHP2.

    Jess M. Cunnick;Songshu Meng;Yuan Ren;Caroline Desponts

Frequent Co-Authors

Sheng Wei
Sheng Wei University of South Florida
Alan F. List
Alan F. List Precision BioSciences
Thomas P. Loughran
Thomas P. Loughran University of Virginia
Thomas W. Klein
Thomas W. Klein University of South Florida
Herman Friedman
Herman Friedman University of South Florida
Ronald B. Herberman
Ronald B. Herberman University of Pittsburgh
John R. Ortaldo
John R. Ortaldo National Institutes of Health
Harvey M. Friedman
Harvey M. Friedman University of Pennsylvania
George C. Tsokos
George C. Tsokos Harvard Medical School
Jody Manischewitz
Jody Manischewitz US Food and Drug Administration

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens up diverse career pathways, especially in healthcare and research sectors. Many professionals in immunology transition into nursing specializations, where a strong understanding of the immune system can enhance patient care. For instance, nurses looking to advance can explore how to transition from fnp to acnp, enabling them to work in acute care settings with a focus on complex immunological conditions.

For those starting fresh in healthcare, enrolling in online programs can be a practical choice. Prospective students without a nursing background might consider online rn programs for non nurses, which provide a streamlined path into nursing, incorporating foundational science useful for immunology careers.

Accelerated programs also cater to individuals seeking faster entry into the nursing profession. Top options for these are detailed in the guide on accelerated nurse practitioner program, designed to prepare students efficiently for advanced clinical roles that often involve immunological expertise.

Moreover, earning advanced degrees can significantly impact earning potential. Understanding dnp salary variations helps in making informed decisions about specialization. Detailed insights into dnp salary by specialty shed light on lucrative pathways within nursing, especially for those focusing on immunology and related fields.

Best Scientists Citing Julie Y. Djeu

Trending Scientists

Recently Published Articles